Answers are grounded in this paper and cite their sources.
The in vivo release profile of the DEX implant in an animal eye was similar to the pharmacokinetics achieved with pulse administration of corticosteroids (high initial drug concentration, followed by a prolonged period of low concentration). These results are consistent with those in clinical studies supporting the use of the DEX implant for the extended management of posterior segment diseases.
No takes yet. Share an insight, caveat, or question.
Chang-Lin et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: